HIPK2 inhibition suppresses the adriamycin-induced apoptosis in chemoresistant cancer cells, whereas overexpression of HIPK2 triggers apoptosis in chemoresistant cells, associated with induction of p53Ser46-target gene AIP1 [14], [15], [16]. Here, HIPK2 is linked to cancer.